FRED ALGER MANAGEMENT, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 3520 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$220,137

-$61,395 QoQ

Shares Held

1,671

-15.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FRED ALGER MANAGEMENT, LLC holds $17,745,861 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	136,254	$10,334,865
2	UTHR	UNITED THERAPEUTICS Corp	4,522	$2,681,455
3	TEVA	Teva Pharmaceutical Industries Ltd	81,865	$2,465,773
4	BCRX	Biocryst Pharmaceuticals Inc	123,961	$1,180,108
5	ZTS	Zoetis Inc.	7,305	$863,523
6	NBIX	Neurocrine Biosciences Inc This page	1,671	$220,137

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$220,137	1,671	-15.8%	Shares	Sole	2026-05-15
2025-12-31	$281,532	1,985	-6.5%	Shares	Sole	2026-02-17
2025-09-30	$297,886	2,122	+5.6%	Shares	Sole	2025-11-14
2025-06-30	$252,511	2,009	-11.7%	Shares	Sole	2025-08-14
2025-03-31	$251,504	2,274	-69.0%	Shares	Sole	2025-05-16
2023-12-31	$966,986	7,339	-91.8%	Shares	Sole	2024-02-14
2023-09-30	$10,118,025	89,938	+51001.1%	Shares	Sole	2023-11-14
2023-03-31	$17,814	176	-99.9%	Shares	Sole	2023-05-16
2022-12-31	$24,687,889	206,697	+92175.4%	Shares	Sole	2023-02-14
2022-09-30	$23,791	224	0.0%	Shares	Sole	2022-11-15
2022-06-30	$21,835	224	-97.1%	Shares	Sole	2022-08-15
2020-03-31	$672,926	7,775	—	Shares	Sole	2020-05-19
No filing history on record for this holder in this stock.